-
-->
Board of Directors
The Anticoagulation Forum Board of Directors represent a multidisciplinary group of anticoagulation care providers including physicians, pharmacists and nurses. These members serve as active participants in the AC Forum’s mission of educational programming for our membership. As experts in the field, our board members are an integral part of our conference faculty, webinar panels, guidance development, and program committees. We are grateful for the generosity of their service and the opportunity to have such an extraordinary group of leaders to oversee the activities of the Anticoagulation Forum.
President
Scott Kaatz is Clinical Professor of Medicine at Wayne State University and a Hospitalist at Henry Ford Hospital in Detroit where he serves as the Medical Director for Professional Development and Research in the Division of Hospital Medicine. He attended medical school at Michigan State University and completed his residency in internal medicine at Henry Ford Hospital. ...more...
Arthur Allen received his doctor of pharmacydegree from the University of Tennessee Health Science Center College of Pharmacy in Memphis, Tennessee in 2000 and completed a pharmacy practice residency at the Memphis VA Medical Center in 2001. He worked as a Clinical Pharmacy Specialist at the VA Sierra Nevada Health Care system in Reno, Nevada from 2001 –2014 where he practiced in ambulatory care and the anticoagulation service. In 2007 he was named the Anticoagulation Program Manager and shortly thereafter focused his time on anticoagulation and thrombosis full-time. ...more...
Founder, Past President
Jack Ansell is former Chairman of Medicine, Lenox Hill Hospital and Professor of Medicine at Hofstra-Northwell School of Medicine. He is a clinical investigator with a principal focus on the clinical problems of thrombosis, antithrombotic therapy, and the application of new modes of delivering and monitoring anticoagulants. ...more...
Geoff Barnes is an Assistant Professor of Internal Medicine at the University of Michigan where he specializes in cardiovascular and vascular medicine. He has completed internal medicine, cardiovascular medicine, and vascular medicine training at the University of Michigan where he also served as the chief medical resident. ...more...
Marilyn Blumenstein works at The Children's Hospital of Philadelphia as a pediatric nurse practitioner in the Hemostasis and Thrombosis Center (HTC). For more than 16 years, her work-focus has been to establish and grow the thrombosis and anticoagulation program at CHOP working closely with the HTC medical director, Leslie Raffini, and in collaboration with our clinical pharmacist for anticoagulation. Prior to her work at CHOP, Marilyn spent 10 years working for the American Red Cross, Penn-Jersey Region in Clinical Services ...more...
Government Liaison
Dr. Budnitz directs the Medication Safety Program at the U.S. Centers for Disease Control and Prevention (CDC). His work in medication safety, public health surveillance, and injury prevention has led to implementation of new safety policies by CMS and FDA as well as a Federal Action Plan for prevention of adverse drug events. Dr. Budnitz also launched the PROTECT Initiative, a public-private partnership to reduce medication overdoses in children through implementation of new child-resistant packaging, standards for dosing instructions, and a national public education campaign (UpAndAway.org). ...more...
President Elect
Allison Burnett received her doctor of pharmacy degree from the University of New Mexico College of Pharmacy in 2003. She completed a general practice pharmacy residency at Boston Medical Center in 2004. She then returned to New Mexico and accepted a clinical pharmacy position at Lovelace Medical Center. ...more...
Nathan P. Clark completed his doctor of pharmacy at North Dakota State University and pharmacy practice residency at Merit Care Health System in Fargo, ND. He is a board-certified pharmacotherapy specialist and a fellow in the American College of Clinical Pharmacy. ...more...
Immediate Past President
Mark Crowther received his M.D. from the University of Western Ontario in 1990. Dr Crowther’s research interests include exploring ways of improving the way that we use our current anticoagulant drugs. These include exploring established and novel interventions to mitigate bleeding, and studies of currently available anticoagulant drugs in high-risk patient populations. ...more...
Adam Cuker is an Assistant Professor of Medicine and Pathology & Laboratory Medicine at the University of Pennsylvania. He received his M.D. from Yale University and completed an internship and residency in internal medicine at Brigham and Women’s Hospital and Harvard Medical School. ...more...
William E. Dager, Pharm.D., BCPS (AQ-Cardiology), is a cardiovascular pharmacist specialist in at UC Davis Medical Center and is the PGY-2 cardiology program director. Dr. Dager holds two academic positions and four fellowship honors and is a board certified pharmacotherapy specialist with added qualifications in cardiology. ...more...
Steven B. Deitelzweig serves as the System Chairman for Hospital Medicine and Medical Director of Regional Business Development of Ochsner Health System in New Orleans, Louisiana. He collaborates on clinical solutions to over 20 partner hospitals within the Ochsner system. ...more...
Stacy Ellsworth is a clinical research coordinator for the Henry Ford Health System in Detroit, MI, with a specialty in anticoagulation research and DVT prevention and treatment. She received her nursing Diploma from Henry Ford Hospital in 1994 and went on to get her Master’s degree in nursing from the University of Phoenix in 2001. ...more...
Past President
David Garcia completed internal medicine residency at The Johns Hopkins Hospital and hematology fellowship at the University of Washington. He has been Professor of Medicine in the Division of Hematology at the University of Washington since 2013. ...more...
Eva Kline-Rogers currently works as a Cardiovascular Nurse Practitioner and co-director for MCORRP (Michigan Cardiovascular Outcomes Research and Reporting Program) at the University of Michigan. She also functions as a project manager/QI Coordinator for several on-going state-wide and international registries, including the Michigan Anticoagulation Quality Improvement Initiative (MAQI2) and the US Fibromuscular Dysplasia Registry. ...more...
Tracy Minichiello is a Professor of Medicine at University of California San Francisco and the Chief of Anticoagulation and Thrombosis Services at UCSF-affiliated San Francisco VA Hospital. After completing her Internal Medicine Residency and Chief Residency at Yale, Dr. Minichiello pursued fellowship in Hospital Medicine at University of California San Francisco’s Moffitt-Long Hospital, where her research and clinical work were focused on venous thromboembolic disease. ...more...
Charles Pollack is Associate Provost for Innovation in Education; Director, Institute of Emerging Health Professions; Associate Dean for CME and Strategic Partner Alliances; and Professor and Senior Advisor for Interdisciplinary Research and Clinical Trials, Department of Emergency Medicine, Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia. ...more...
Sara Vazquez is a clinical pharmacist and specializes in thrombosis management at the University of Utah Health Thrombosis Service in Salt Lake City. She earned her pharmacy degree from the University of Tennessee College of Pharmacy and completed a Pharmacy Practice Residency with Ambulatory Care Emphasis at the Regional Medical Center in Memphis, TN. ...more...